SSA
AMAG

Schonfeld Strategic Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-84,437
Closed -$2.94M – 793
2016
Q4 		$2.94M Buy
+84,437
New +$2.52M 0.38% 69

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors's AMAG Position: Q1 2017 in Review

Schonfeld Strategic Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q1 2017, closing a stake of 84,437 shares — an estimated $2.94M sold.

Schonfeld Strategic Advisors first reported a position in AMAG in Q4 2016 and held it in 1 quarter. The position peaked at $2.94M in Q4 2016. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

  • Schonfeld Strategic Advisors reported no remaining AMAG Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 84,437 AMAG Pharmaceuticals shares in Q1 2017, an estimated $2.94M.
  • Schonfeld Strategic Advisors first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's AMAG Pharmaceuticals position peaked at $2.94M in Q4 2016.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2017, filed 15 May 2017.